ListedMainboardWINDLAS
Windlas Biotech Limited
Windlas Biotech Limited is a mainboard IPO raising ₹165 Cr at ₹448 – ₹460 a share. It listed on 16 Aug 2021 and trades at ₹849 today, +84.5% against its issue price of ₹460. It was subscribed 22× in total.
₹460
Issue price
₹849
Price now
+84.5%
Since issue price
16 Aug 2021
Listed on
22×Subscribed (final) · all exchanges
22.5 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| QIB Banks, funds and other large institutions | 17,23,700 | 4,20,65,880 | 24× |
| Foreign Institutional Investors | no separate quota | 1,92,76,020 | n/a |
| Domestic Financial Institutions | no separate quota | 1,69,31,850 | n/a |
| Mutual funds | no separate quota | 18,09,840 | n/a |
| Others | no separate quota | 40,48,170 | n/a |
| Non-institutional Wealthy individuals and companies bidding above ₹2 lakh | 13,23,766 | 2,08,26,420 | 16× |
| Corporates | no separate quota | 38,12,280 | n/a |
| Individuals | no separate quota | 1,16,62,650 | n/a |
| others | no separate quota | 53,51,490 | n/a |
| Retail Ordinary investors bidding up to ₹2 lakh | 30,88,786 | 7,49,61,960 | 24× |
| Cut Off | no separate quota | 5,75,80,350 | n/a |
| Price bids | no separate quota | 1,73,81,610 | n/a |
| Total | 61,36,252 | 13,78,54,260 | 22× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 07:24 pm IST.
How demand built
We hold no subscription readings for this issue.